A new study suggests additional drug shows promise for women with triple-negative breast cancer.
Credit
Dana-Farber Cancer Institute
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.